Goal of the analysis:
Identify and evaluate any discrepancies between a company’s current medical device or in vitro diagnostic (IVD) compliance status and the requirements set forth by the EU Medical Device Regulation (MDR 2017/745) or In Vitro Diagnostic Regulation (IVDR 2017/746). Develop a clear action plan to close these gaps and ensure regulatory conformity.
Data required:
- Current technical documentation, including device description, design data, risk management, and clinical evidence
- Existing conformity assessment documentation under previous directives (for example, MDD or IVDD)
- Post-market surveillance (PMS) plans and reports
- Labeling and instructions for use (IFU), including UDI details
- Quality Management System (for example, ISO 13485) documentation
- Contracts and agreements with Notified Bodies, if applicable
- Device classification according to MDR or IVDR rules
Detailed step-by-step instruction on how to conduct the analysis:
- Gather applicable MDR/IVDR requirements. Obtain the latest regulations, guidance documents, and relevant harmonized standards for your device type.
- Review current technical documentation. Compare each section (for example, design and manufacturing info, risk management, clinical evaluation) against the MDR/IVDR requirements to pinpoint gaps.
- Examine device classification. Confirm that the device classification under MDR or IVDR is correct and determine the specific conformity assessment route.
- Assess clinical evaluation or performance evaluation. Check clinical data sufficiency under the stricter MDR or IVDR requirements, including post-market follow-up obligations.
- Analyze post-market surveillance procedures. Evaluate whether current processes meet new requirements for PMS, post-market clinical follow-up (PMCF), or post-market performance follow-up (PMPF).
- Check labeling and UDI compliance. Verify that labeling meets MDR/IVDR specifications and ensure a plan is in place for UDI assignment and registration.
- Identify documentation gaps. List specific areas (for example, insufficient clinical evidence, outdated risk management) that fail to meet MDR/IVDR standards.
- Develop a remediation plan. Propose corrective actions, timelines, and responsibilities to address identified deficiencies and achieve full compliance.
Format of the output of analysis:
- A written gap analysis report mapping each regulatory requirement to current documentation
- A table or spreadsheet listing identified gaps with severity, proposed remediation steps, and responsible teams
- An implementation timeline showing milestones for upgrading documentation, processes, and systems
- A high-level summary for senior management outlining resource and budget needs
How to interpret results:
- The number and severity of identified gaps indicate the level of effort needed to achieve MDR/IVDR compliance.
- Minor gaps (for example, documentation format issues) may be resolved quickly, whereas major gaps (for example, missing clinical data) require longer-term planning.
- Timely and systematic remediation of gaps mitigates the risk of noncompliance, product withdrawal, or Notified Body certification delays.
Steps a company can take to improve on this measure:
- Invest in expert regulatory resources or external consultants with EU MDR/IVDR experience.
- Enhance clinical evidence and post-market surveillance programs to meet stricter requirements.
- Implement a robust Quality Management System that aligns with ISO 13485 and MDR/IVDR guidelines.
- Establish ongoing training programs to ensure staff understand evolving MDR/IVDR obligations.
- Maintain close communication with Notified Bodies to clarify expectations, submission timelines, and ongoing compliance requirements.
